Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer

Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

(2014) Christian M. Zechmann et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Phase II Study of Lutetium-177-Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

(2013) S. T. Tagawa et al.   CLINICAL CANCER RESEARCH

Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2

(2013) René Martin et al.   NUCLEAR MEDICINE AND BIOLOGY

Simplified NaCl Based 68Ga Concentration and Labeling Procedure for Rapid Synthesis of 68Ga Radiopharmaceuticals in High Radiochemical Purity

(2012) Dirk Mueller et al.   BIOCONJUGATE CHEMISTRY

68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

(2012) Matthias Eder et al.   BIOCONJUGATE CHEMISTRY

DOTAGA-Anhydride: A Valuable Building Block for the Preparation of DOTA-Like Chelating Agents

(2012) Claire Bernhard et al.   CHEMISTRY-A EUROPEAN JOURNAL

A Monoreactive Bifunctional Triazacyclononane Phosphinate Chelator with High Selectivity for Gallium-68

(2012) Jakub Šimeček et al.   ChemMedChem

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

(2012) A. Afshar-Oromieh et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer

(2012) S. Y. Cho et al.   JOURNAL OF NUCLEAR MEDICINE

TRAP, a Powerful and Versatile Framework for Gallium-68 Radiopharmaceuticals

(2011) Johannes Notni et al.   CHEMISTRY-A EUROPEAN JOURNAL

68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer

(2010) Sangeeta Ray Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Remote Arene-Binding Site on Prostate Specific Membrane Antigen Revealed by Antibody-Recruiting Small Molecules

(2010) Andrew X. Zhang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer

(2009) S. M. Hillier et al.   CANCER RESEARCH

Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted99mTc-Radioimaging Agents

(2009) Sumith A. Kularatne et al.   MOLECULAR PHARMACEUTICS

N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer

(2008) R. C. Mease et al.   CLINICAL CANCER RESEARCH

Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)

(2008) Sangeeta R. Banerjee et al.   JOURNAL OF MEDICINAL CHEMISTRY

Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer

(2008) Ying Chen et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer

(2008) K. P. Maresca et al.   JOURNAL OF MEDICINAL CHEMISTRY